Q-omics provides the consensus-scored GOLGA2P4 profile across patient tissues and cancer cell-line models. GOLGA2P4 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, GOLGA2P4 is differentially expressed in 4, with the highest sampling consensus in THCA. Additionally, GOLGA2P4 RNA expression shows 8,454 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight HNSC, THCA, and TGCT as cancer lineages where GOLGA2P4 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for GOLGA2P4 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes GOLGA2P4 survival associations across molecular data types. GOLGA2P4 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible GOLGA2P4 RNA expression–survival associations across cancer types. High GOLGA2P4 expression shows unfavorable associations in ACC, TGCT, OV and THCA, but favorable associations in HNSC and PAAD. The HNSC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify HNSC as the clearest survival context for GOLGA2P4 RNA expression.
This table summarizes GOLGA2P4 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for GOLGA2P4. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. GOLGA2P4 shows lower tumor expression in THCA and LUAD and higher tumor expression in KICH and HNSC. The THCA box plot shows higher GOLGA2P4 RNA expression in normal versus tumor tissue (log2 FC = −0.455, t-test p < 0.001).
This table shows molecular features associated with GOLGA2P4 in patient tissues and cancer cell lines. In patient samples, GOLGA2P4 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
